{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T12:58:58Z","timestamp":1761310738731},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,11,9]],"date-time":"2011-11-09T00:00:00Z","timestamp":1320796800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s10689-011-9487-1","type":"journal-article","created":{"date-parts":[[2011,11,8]],"date-time":"2011-11-08T10:26:17Z","timestamp":1320747977000},"page":"131-136","source":"Crossref","is-referenced-by-count":6,"title":["Case report: a p.C618S RET proto-oncogene germline mutation in a large Chinese pedigree with familial medullary thyroid carcinoma"],"prefix":"10.1007","volume":"11","author":[{"given":"X.-P.","family":"Qi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.-B.","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-M.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.-T.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.-F.","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Fei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.-P.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.-Z.","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-Y.","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.-G.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-S.","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-Q.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.-L.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-J.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.-N.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,9]]},"reference":[{"key":"9487_CR1","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/thy.2008.0403","volume":"19","author":"RT Kloos","year":"2009","unstructured":"Kloos RT, Eng C et al (2009) Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 19:565\u2013612","journal-title":"Thyroid"},{"key":"9487_CR2","doi-asserted-by":"crossref","first-page":"e20353","DOI":"10.1371\/journal.pone.0020353","volume":"6","author":"XP Qi","year":"2011","unstructured":"Qi XP, Ma JM et al (2011) RET germline mutations identified by exome sequencing in a Chinese multiple endocrine neoplasia type 2A\/familial medullary thyroid carcinoma family. Plos One 6:e20353","journal-title":"Plos One"},{"key":"9487_CR3","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jama.1996.03540190047028","volume":"276","author":"C Eng","year":"1996","unstructured":"Eng C, Clayton D et al (1996) The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 276:1575\u20131579","journal-title":"JAMA"},{"key":"9487_CR4","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10689-010-9320-2","volume":"9","author":"F Raue","year":"2010","unstructured":"Raue F, Frank-Raue K (2010) Update multiple endocrine neoplasia type 2. Fam Cancer 9:449\u2013457","journal-title":"Fam Cancer"},{"key":"9487_CR5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2010.01.012","volume":"322","author":"K Frank-Raue","year":"2010","unstructured":"Frank-Raue K, Rondot S, Raue F (2010) Molecular genetics and phenomics of RET mutations: impact on prognosis of MTC. Mol Cell Endocrinol 322:2\u20137","journal-title":"Mol Cell Endocrinol"},{"key":"9487_CR6","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1073\/pnas.89.5.1616","volume":"89","author":"MA Pierotti","year":"1992","unstructured":"Pierotti MA, Santoro M et al (1992) Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET\/PTC. Proc Natl Acad Sci 89:1616\u20131620","journal-title":"Proc Natl Acad Sci"},{"key":"9487_CR7","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/hmg\/2.7.851","volume":"2","author":"H Donis-Keller","year":"1993","unstructured":"Donis-Keller H, Dou S et al (1993) Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 2:851\u2013856","journal-title":"Hum Mol Genet"},{"key":"9487_CR8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/(SICI)1098-1004(1997)9:2<97::AID-HUMU1>3.0.CO;2-M","volume":"9","author":"C Eng","year":"1997","unstructured":"Eng C, Mulligan L (1997) Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschsprung disease. Hum Mutat 9:97\u2013109","journal-title":"Hum Mutat"},{"key":"9487_CR9","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3346\/jkms.2010.25.2.226","volume":"25","author":"J Jung","year":"2010","unstructured":"Jung J, Uchino S et al (2010) A Korean family of familial medullary thyroid cancer with Cys618Ser RET germline mutation. J Korean Med Sci 25:226\u2013229","journal-title":"J Korean Med Sci"},{"key":"9487_CR10","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1210\/jc.82.12.4176","volume":"82","author":"RM Hofstra","year":"1997","unstructured":"Hofstra RM, Fattoruso O et al (1997) A novel point mutation in the intracellular domain of the RET protooncogene in a family with medullary thyroid carcinoma. J Clin Endocrinol Metab 82:4176\u20134178","journal-title":"J Clin Endocrinol Metab"},{"key":"9487_CR11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10689-006-6990-x","volume":"5","author":"T Dabir","year":"2006","unstructured":"Dabir T, Hunter SJ et al (2006) The RET mutation E768D confers a late-onset familial medullary thyroid carcinoma\u2014only phenotype with incomplete penetrance: implications for screening and management of carrier status. Fam Cancer 5:201\u2013204","journal-title":"Fam Cancer"},{"key":"9487_CR12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.biopha.2004.05.001","volume":"58","author":"K Kameyama","year":"2004","unstructured":"Kameyama K, Okinaga H, Takami H (2004) RET oncogene mutations in 75 cases of familial medullary thyroid carcinoma in Japan. Biomed Pharmacother 58:345\u2013347","journal-title":"Biomed Pharmacother"},{"key":"9487_CR13","doi-asserted-by":"crossref","first-page":"5438","DOI":"10.1210\/jc.2003-030997","volume":"88","author":"AM Da Silva","year":"2003","unstructured":"Da Silva AM, Maciel RM et al (2003) A novel germ-line point mutation in RET exon 8 (Gly533Cys) in a large kindred with familial medullary thyroid carcinoma. J Clin Endocrinol Metab 88:5438\u20135443","journal-title":"J Clin Endocrinol Metab"},{"key":"9487_CR14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/thy.2006.0198","volume":"17","author":"G Pinna","year":"2007","unstructured":"Pinna G, Orgiana G et al (2007) RET proto-oncogene in Sardinia: V804\u00a0M is the most frequent mutation and may be associated with FMTC\/MEN-2A phenotype. Thyroid 17:101\u2013104","journal-title":"Thyroid"},{"key":"9487_CR15","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2265.2009.03757.x","volume":"73","author":"MD Castellone","year":"2010","unstructured":"Castellone MD, Verrienti A et al (2010) A novel de novo germ-line V292\u00a0M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: functional characterization. Clin Endocrinol (Oxf) 73:529\u2013534","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9487_CR16","first-page":"3025","volume":"9","author":"I Ceccherini","year":"1994","unstructured":"Ceccherini I, Hofstra RM et al (1994) DNA polymorphisms and conditions for SSCP analysis of the 20 exons of the ret proto-oncogene. Oncogene 9:3025\u20133029","journal-title":"Oncogene"},{"key":"9487_CR17","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1210\/jc.2003-031898","volume":"89","author":"R Elisei","year":"2004","unstructured":"Elisei R, Cosci B et al (2004) RET exon 11 (G691S) polymorphism is significantly more frequent in sporadic medullary thyroid carcinoma than in the general population. J Clin Endocrinol Metab 89:3579\u20133584","journal-title":"J Clin Endocrinol Metab"},{"key":"9487_CR18","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/jmg.36.10.771","volume":"36","author":"S Borrego","year":"1999","unstructured":"Borrego S, Saez ME et al (1999) Specific polymorphisms in the RET proto-oncogene are over-represented in patients with Hirschsprung disease and may represent loci modifying phenotypic expression. J Med Genet 36:771\u2013774","journal-title":"J Med Genet"},{"key":"9487_CR19","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/jmg.39.4.260","volume":"39","author":"F Lesueur","year":"2002","unstructured":"Lesueur F, Corbex M et al (2002) Specific haplotypes of the RET proto-oncogene are over-represented in patients with sporadic papillary thyroid carcinoma. J Med Genet 39:260\u2013265","journal-title":"J Med Genet"},{"key":"9487_CR20","first-page":"1814","volume":"63","author":"M Robledo","year":"2003","unstructured":"Robledo M, Gil L et al (2003) Polymorphisms G691S\/S904S of RET as genetic modifiers of MEN 2A. Cancer Res 63:1814\u20131817","journal-title":"Cancer Res"},{"key":"9487_CR21","doi-asserted-by":"crossref","first-page":"6232","DOI":"10.1210\/jc.2005-1278","volume":"90","author":"SM Baumgartner-Parzer","year":"2005","unstructured":"Baumgartner-Parzer SM, Lang R et al (2005) Polymorphisms in Exon 13 and Intron 14 of the RET protooncogene: genetic modifiers of medullary thyroid carcinoma? J Clin Endocrinol Metab 90:6232\u20136236","journal-title":"J Clin Endocrinol Metab"},{"key":"9487_CR22","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1634\/theoncologist.2009-0046","volume":"14","author":"PJ Morrison","year":"2009","unstructured":"Morrison PJ, Atkinson AB (2009) Genetic aspects of familial thyroid cancer. Oncologist 14:571\u2013577","journal-title":"Oncologist"},{"key":"9487_CR23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2265.2010.03900.x","volume":"74","author":"C Romei","year":"2011","unstructured":"Romei C, Cosci B et al (2011) RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC). Clin Endocrinol (Oxf) 74:241\u2013247","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-011-9487-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-011-9487-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-011-9487-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T14:29:29Z","timestamp":1713104969000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-011-9487-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,9]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["9487"],"URL":"https:\/\/doi.org\/10.1007\/s10689-011-9487-1","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,9]]}}}